d.bramley

TL3 Regular · Trieste, IT

Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.

Joined 1 February 2025 · last posted 16h

143 posts, newest first. Showing up to 150.

Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #15 · Compounds › Retatrutide · 27 Jul 2026 · 19 likes Building on post #14 rather than restating it. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #68 · Access › Insurance & coverage · 25 Jul 2026 · 1 like What does not work: describing how the decision made you feel, however justified. The reviewer is checking criteria and the job is to make them checkable. I would want…
Which categories are strict and which are relaxed, honestly Replied, post #41 · Start Here › Welcome · 23 Jul 2026 · 10 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
What a reversed-phase purity number actually is Replied, post #80 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 12 likes A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #108 · Analytics › Home & field testing · 21 Jul 2026 · 8 likes On post #106 — agreed on the reasoning, with one qualification. Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #21 · Clinical › Prescriber conversations · 20 Jul 2026 · 23 likes Write the questions down in advance and put the most important one first. Appointments end and the order is what decides which questions get answered. Happy to be…
Why the Start Here categories exist, and what they are not for Replied, post #14 · Start Here › Welcome · 19 Jul 2026 · 17 likes A methods point on Start rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #90 · Analytics › Method validation · 14 Jul 2026 · 18 likes Post #89 describes the usual case. This is about the unusual one. System suitability: injections run at the start of a batch to establish that the instrument and column…
Substitution between formats during a shortage — what changed since Replied, post #12 · Access › Shortages · 14 Jul 2026 · 0 likes A shortage of one presentation is not a shortage of all of them, and the published notices are specific about which.
Why we ask for units every single time, with three examples of what goes wrong Replied, post #125 · Start Here › How to Ask · 13 Jul 2026 · 28 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #41 · Practice › Dosing & titration · 6 Jul 2026 · 4 likes Adding the measurement that post #40 says would settle it. Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to…
Journal club: what we got wrong in an earlier session Replied, post #53 · Evidence › Journal club · 4 Jul 2026 · 0 likes Worth separating two things that post #51 runs together. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #66 · Wellbeing › Sleep · 23 Jun 2026 · 15 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #2 · Compounds › Secretagogues & GH axis · 19 Jun 2026 · 26 likes The bit of Reading a rodent study that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
A checklist for reading a certificate in under two minutes Replied, post #43 · Analytics › COA interpretation · 18 Jun 2026 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Why retatrutide discussion here is more cautious than elsewhere — one year on Started this topic · Compounds › Retatrutide · 15 Jun 2026 · 18 likes Asking directly, because I could not find a straight answer: Why retatrutide discussion here is more cautious than elsewhere — one year on Two things I would like…
How to ask a question when you cannot say why you are asking it Replied, post #13 · Start Here › How to Ask · 14 Jun 2026 · 0 likes Where I part company with post #11, and it is a narrow parting. A question about somebody else's post should be a reply to that post, not a new topic. A question the…
Lipid changes during rapid weight loss: the expected trajectory Replied, post #4 · Clinical › Bloodwork · 11 Jun 2026 · 23 likes Agreed on lipid changes during rapid weight, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #2 · Sourcing › Independent verification · 4 Jun 2026 · 0 likes Requesting the batch record rather than the certificate is a reasonable escalation and the response tells you about the operation either way.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #12 · Practice › Storage & stability · 30 May 2026 · 4 likes Two sentences on Mean kinetic temperature and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
The most useful thing you learned here that was not the answer you came for Replied, post #43 · Lounge › Off topic · 18 May 2026 · 8 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #77 · Outcomes › Body composition · 16 May 2026 · 23 likes Genuine question rather than a rhetorical one: has anyone here actually observed Lean mass preservation, as opposed to read about it? The thread is long and I cannot…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #106 · Research Methods › Statistics · 16 May 2026 · 0 likes Building on post #103 rather than restating it. The most useful thing anyone has posted about Measurement error in home scales in this category was a table of what had…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #41 · Practice › Administration · 16 May 2026 · 16 likes A new needle for each injection is not fussiness. A needle blunts on first use and a blunted needle is the reason the second injection hurts more than the first. Adding…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #31 · Wellbeing › Sleep · 9 May 2026 · 29 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
Insomnia at a dose step: reported experiences — the long version Replied, post #18 · Wellbeing › Sleep · 4 May 2026 · 2 likes I think the Insomnia question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Amylin receptor signalling and satiety — what changed since Replied, post #73 · Pharmacology › Receptor biology · 4 May 2026 · 0 likes Post #69 describes the usual case. This is about the unusual one. Where I have landed on Amylin receptor signalling and satiety, having got it wrong once in public: the…
What a certificate commits its issuer to — one year on Replied, post #60 · Analytics › COA interpretation · 2 May 2026 · 5 likes A stability statement tied to a named storage condition can be evaluated. One without a condition attached cannot be evaluated at all and is decoration.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #116 · Analytics › Mass spectrometry · 26 Apr 2026 · 21 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
The best-written scientific paper you have read Replied, post #18 · Lounge › Off topic · 25 Apr 2026 · 1 like Two people in this thread mean different things by best-written scientific paper and are disagreeing about the definition while believing they are disagreeing about the…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #94 · Practice › Reconstitution · 24 Apr 2026 · 15 likes On a U-100 insulin syringe, one hundred units is one millilitre and one unit is 0.01 millilitres. Units are volume marks. They mean nothing until you know the…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #21 · Practice › Reconstitution · 23 Apr 2026 · 0 likes This follows post #18 rather than contradicting it. Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #75 · Practice › Reconstitution · 22 Apr 2026 · 1 like Narrowing post #72, because the general version has more than one answer. Preservative effectiveness is tested against a defined microbial challenge under defined…
Forced degradation studies: designing one that is informative Replied, post #39 · Analytics › Method validation · 18 Apr 2026 · 7 likes Where I part company with post #35, and it is a narrow parting. Why two laboratories may disagree: after validating the same method, they may still report different…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #9 · Practice › Reconstitution · 17 Apr 2026 · 0 likes I read post #5 twice before replying, because I had assumed the opposite. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you…
List price versus negotiated price versus what you pay Replied, post #29 · Access › Pricing · 10 Apr 2026 · 8 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Spike-and-recover accuracy for a peptide assay Replied, post #96 · Analytics › Method validation · 10 Apr 2026 · 0 likes The confident answers on spike-and-recover accuracy and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
Travelling with an injectable: documentation and practicalities Replied, post #19 · Access › International · 3 Apr 2026 · 7 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #19 · Evidence › Trials · 24 Mar 2026 · 0 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
[2026 update] Thyroid function tests during substantial weight change Replied, post #18 · Clinical › Bloodwork · 19 Mar 2026 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #88 · Lounge › Introductions · 17 Mar 2026 · 0 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community. I am confident about the…
A site rotation scheme that is easy enough to actually follow Replied, post #20 · Practice › Administration · 14 Mar 2026 · 21 likes What I can speak to on site rotation scheme is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Citation sweep results: how many references did not say what was claimed Replied, post #60 · Meta › Wiki maintenance · 14 Mar 2026 · 27 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. One case, stated as one case.
[2026 update] Charge states for a 4 kDa peptide, worked through Started this topic · Analytics › Mass spectrometry · 8 Mar 2026 · 0 likes On the subject in the title: Charge states for a 4 kDa peptide, worked through Working notes rather than a conclusion. Working through the identity arithmetic and I…
Foaming during reconstitution and whether it matters — the long version Replied, post #54 · Practice › Reconstitution · 6 Mar 2026 · 0 likes Small correction to my own earlier position on Foaming during reconstitution. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
Five questions in one post gets you one answer — how to split them Replied, post #25 · Start Here › How to Ask · 6 Mar 2026 · 1 like A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
The lowest dose that does anything: is that a real question? Replied, post #49 · Practice › Dosing & titration · 4 Mar 2026 · 32 likes Confirming post #47 from a second method, which matters more than confirming it from a second person. Titrating on tolerability rather than on the calendar: some people…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #33 · Compounds › Tirzepatide · 4 Mar 2026 · 1 like Narrowing post #32, because the general version has more than one answer. The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #30 · Sourcing › Vendor reports · 3 Mar 2026 · 32 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
Why a compound being unapproved is not the same as being illegal to possess Replied, post #61 · Sourcing › Regulatory · 21 Feb 2026 · 1 like If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #70 · Analytics › Impurities & related substances · 19 Feb 2026 · 1 like The arithmetic in post #67 is right; the assumption feeding it is the part to check. Truncation products: fragments from incomplete synthesis or from degradation. They…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #17 · Practice › Reconstitution · 18 Feb 2026 · 20 likes Taking post #14 at face value and following it one step further. Where I would push back on the Choosing a concentration consensus is the confidence, not the direction.…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #75 · Documentation › Wiki requests · 6 Feb 2026 · 30 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important.
Trifluoroacetate content and its consequences Replied, post #17 · Analytics › Impurities & related substances · 24 Jan 2026 · 3 likes The arithmetic in post #16 is right; the assumption feeding it is the part to check. Whatever the answer on trifluoroacetate content turns out to be, the method for…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #49 · Sourcing › Red flags · 14 Jan 2026 · 0 likes Post #45 put the caveat in the right place and I want to underline it. Being wrong in public about a supplier is costly to that supplier and to the person who was…
Coming back to: Training through a dose escalation week Replied, post #8 · Nutrition & Training › Resistance training · 14 Jan 2026 · 1 like Counterpoint on Training through a dose escalation, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #83 · Compounds › Semaglutide · 1 Jan 2026 · 23 likes I would keep semaglutide half-life and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging…
Vomiting: when it is expected and when it is a reason to stop Replied, post #79 · Practice › Side effects · 29 Dec 2025 · 6 likes Severe, persistent abdominal pain, especially radiating to the back, is in a different category from ordinary gastrointestinal upset and is a reason to seek medical…
Publication bias detection and its low power — does this still hold? Replied, post #4 · Evidence › Meta-analyses · 27 Dec 2025 · 21 likes That is clearer than the version I had in my head. Thank you.
Search filters: what is missing Replied, post #11 · Meta › Site feedback · 20 Dec 2025 · 2 likes That is the distinction I keep failing to hold on to. Written down now.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #38 · Access › Pricing · 16 Dec 2025 · 1 like Price differences within a market are usually about scale, documentation and logistics rather than about anything mysterious. The literature is thinner on this than the…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #113 · Documentation › Doc review · 16 Dec 2025 · 10 likes Confirming post #110 from a second method, which matters more than confirming it from a second person. Promotion criteria was covered in the wiki last year and the page…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #6 · Sourcing › Logistics · 10 Dec 2025 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
Publishing an inconvenient result: a case study — the long version Replied, post #63 · Sourcing › Independent verification · 8 Dec 2025 · 1 like Everything in post #61 holds. The case it does not cover is the one I have. The useful distinction on Publishing an inconvenient result is between what was measured and…
Where the integrator drew the baseline, and how much it moved the number Replied, post #24 · Analytics › HPLC & UHPLC · 3 Dec 2025 · 7 likes Where I would push back on the integrator consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Moderation log format change Replied, post #10 · Meta › Announcements · 23 Nov 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on moderation log format change, because it is the sort of subject…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #27 · Compounds › Other compounds · 23 Nov 2025 · 0 likes Picking up post #24: that is the part I would want checked first. Reframing Sequence verification slightly, because I think the disagreement is about the question…
Pen dose counters: what a click does and does not guarantee Replied, post #12 · Devices › Pens & autoinjectors · 12 Nov 2025 · 27 likes Building on post #11 rather than restating it. Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not…
[2026 update] What steady state means for the decision to escalate Replied, post #35 · Practice › Dosing & titration · 8 Nov 2025 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #106 · Compounds › Tirzepatide · 23 Oct 2025 · 3 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #25 · Sourcing › Regulatory · 18 Oct 2025 · 27 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #74 · Documentation › Doc review · 14 Oct 2025 · 14 likes What I would tell a new member reading about Promotion criteria for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #48 · Compounds › Oral incretins · 11 Oct 2025 · 0 likes Confirming post #46 from a second method, which matters more than confirming it from a second person. Adding a null result on SOUL trial and oral semaglutide. I looked,…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #142 · Practice › Reconstitution · 10 Oct 2025 · 18 likes Source for the 10 mg vial reconstituted three figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #134 · Practice › Side effects · 9 Oct 2025 · 0 likes Post #133 answers the question as asked. The question underneath it is different. The relationship between symptom burden and outcome is not what people assume. Feeling…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #6 · Evidence › Study critique · 12 Sep 2025 · 12 likes Building on post #4 rather than restating it. Reverse causation: I have looked for the primary source twice and failed twice. Either it does not exist or it is…
Why the timeline is on the right and not the left Replied, post #65 · Meta › Site feedback · 7 Sep 2025 · 1 like The arithmetic in post #62 is right; the assumption feeding it is the part to check. Timeline would be much easier to settle if anyone reported the denominator. Almost…
Meeting a protein target on a suppressed appetite Replied, post #20 · Nutrition & Training › Protein & intake · 7 Sep 2025 · 4 likes This is the first time the answer has come with its own limits attached. Appreciated.
A parcel that arrived warm: a decision process, not a verdict Replied, post #27 · Practice › Storage & stability · 6 Sep 2025 · 18 likes Same experience here, different supplier, so it is at least not unique to one of them.
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #37 · Practice › Dosing & titration · 6 Sep 2025 · 1 like A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
[2026 update] Splitting an overlong document into two Replied, post #30 · Documentation › Wiki requests · 6 Sep 2025 · 21 likes Splitting an overlong document would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #129 · Compounds › Secretagogues & GH axis · 3 Sep 2025 · 3 likes Confirming post #128 from a second method, which matters more than confirming it from a second person. On analysis: these are short peptides and generally…
Second pass at: The mass-error checker and its intended scope Replied, post #10 · Data & Tools › Calculators · 2 Sep 2025 · 2 likes Where I part company with post #6, and it is a narrow parting. The version of mass-error checker that I was taught turned out to be a teaching simplification. Useful,…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #91 · Compounds › Cagrilintide & amylin analogues · 31 Aug 2025 · 22 likes Where I part company with post #89, and it is a narrow parting. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms.…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #49 · Documentation › Doc review · 30 Aug 2025 · 5 likes Picking up post #46: that is the part I would want checked first. On Promotion criteria I would separate what is worth knowing from what is worth acting on. The first…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #2 · Compounds › Semaglutide · 26 Aug 2025 · 4 likes Narrowing the opening post, because the general version has more than one answer. On semaglutide half-life the community has more anecdote than the confidence in this…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #120 · Practice › Reconstitution · 22 Aug 2025 · 5 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Not the…
Adolescents: a distinct evidence base — one year on Replied, post #9 · Clinical › Special populations · 15 Aug 2025 · 0 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. The reason Adolescents keeps being re-asked is that the answer is conditional and…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #70 · Evidence › Trials · 8 Aug 2025 · 0 likes On post #67 — agreed on the reasoning, with one qualification. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
A request that was declined, and the reasoning — a second dataset Replied, post #26 · Documentation › Wiki requests · 8 Aug 2025 · 4 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
Sequence verification for an obscure compound: how it is done Replied, post #111 · Compounds › Other compounds · 1 Aug 2025 · 15 likes Post #109 and I disagree about the size of the effect, not about the direction. The thing about sequence verification that took me longest to accept is that a plausible…
Coming back to: Official shortage notices and what they authorise Replied, post #68 · Access › Shortages · 25 Jul 2025 · 24 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing. The claim is narrower than it…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #44 · Clinical › Special populations · 20 Jul 2025 · 0 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
Counter-ion content and its effect on measured mass Replied, post #87 · Analytics › Mass spectrometry · 9 Jul 2025 · 32 likes Post #86 is right about the mechanism and I think understates the practical bit. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to…
Managing an unplanned gap in supply — what changed since Replied, post #10 · Access › Shortages · 2 Jul 2025 · 0 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another.
Publishing an inconvenient result: a case study Replied, post #42 · Sourcing › Independent verification · 1 Jul 2025 · 14 likes Publishing an inconvenient result looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #59 · Clinical › Comorbidities · 26 Jun 2025 · 9 likes Post #57 put the caveat in the right place and I want to underline it. I disagree with the framing of Cardiovascular risk above, and I think it is a substantive…
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #9 · Analytics › HPLC & UHPLC · 23 Jun 2025 · 0 likes Purity by chromatography answers "what proportion of what I detected is the intended species". It does not answer how much is in the vial, which is a separate assay.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #60 · Clinical › Comorbidities · 8 Jun 2025 · 2 likes On hepatic steatosis, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #32 · Practice › Dosing & titration · 6 Jun 2025 · 8 likes Nothing to add on the substance. Thank you for taking the question at face value.
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #31 · Compounds › Repair & healing peptides · 5 Jun 2025 · 0 likes Agreed on TB-500 and thymosin beta-4, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it…
A report I filed that turned out to be wrong, and the correction Replied, post #86 · Sourcing › Vendor reports · 4 Jun 2025 · 3 likes The arithmetic in post #83 is right; the assumption feeding it is the part to check. A difference inside method repeatability is not a disagreement. Saying so in your…
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #32 · Sourcing › Vendor reports · 4 Jun 2025 · 11 likes Post #30 describes the usual case. This is about the unusual one. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
Cost per milligram, computed honestly across formats — the long version Replied, post #114 · Access › Pricing · 26 May 2025 · 8 likes Nothing here is financial advice and none of it is a route to a transaction. One more caveat and then I will stop qualifying: the sample selected itself.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #72 · Practice › Reconstitution · 18 May 2025 · 4 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #14 · Sourcing › Independent verification · 25 Apr 2025 · 8 likes An observation about Janoshik that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
Preparing for an appointment: one page, three questions Replied, post #14 · Clinical › Prescriber conversations · 10 Apr 2025 · 26 likes Post #13 is the version of this I will quote in future. One addition. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
Carryover and the ghost peak from last week's standard Replied, post #14 · Analytics › HPLC & UHPLC · 2 Apr 2025 · 0 likes Building on post #11 rather than restating it. Carryover is one of those subjects where the general answer and the answer for a specific case diverge, and the thread…
Coming back to: What published stability data actually covers, and what it does not Replied, post #14 · Practice › Storage & stability · 1 Apr 2025 · 10 likes I read post #11 twice before replying, because I had assumed the opposite. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
Retatrutide dose escalation in the published trials Replied, post #64 · Compounds › Retatrutide · 29 Mar 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
Why we hide unevidenced fraud accusations and log the hiding Replied, post #72 · Sourcing › Red flags · 29 Mar 2025 · 0 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. Happy to expand any…
Triple agonism: additive, synergistic, or neither? Replied, post #30 · Compounds › Retatrutide · 26 Mar 2025 · 2 likes Building on post #28 rather than restating it. A note on scope: what I am saying about triple agonism applies to the case in the first post and I would not extend it…
Coverage for the indication versus for the drug Replied, post #7 · Access › Insurance & coverage · 22 Mar 2025 · 1 like Coverage is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Why cagrilintide alone is discussed so much less than in combination Replied, post #7 · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 30 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
Publishing an inconvenient result: a case study Started this topic · Sourcing › Independent verification · 19 Mar 2025 · 16 likes On the subject in the title: Publishing an inconvenient result: a case study Working notes rather than a conclusion. Publishing an inconvenient result, and specifically…
A ten-fold dose error caught before injection Replied, post #10 · Devices › Syringes & needles · 17 Mar 2025 · 0 likes Adding the measurement that post #7 says would settle it. Where the ten-fold dose error caught reasoning breaks down for me is the step from the group result to the…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #94 · Sourcing › Regulatory · 3 Mar 2025 · 21 likes Coming back to post #90, because the follow-up matters more than the original answer. What I would want before treating pharmaceutical compounding rules as settled: the…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #18 · Evidence › Meta-analyses · 28 Jan 2025 · 4 likes The arithmetic in post #15 is right; the assumption feeding it is the part to check. My understanding of Random versus fixed effects is a few years old and may have…
Why mass spectrometry cannot tell you about an epimer Replied, post #26 · Analytics › Mass spectrometry · 13 Jan 2025 · 15 likes Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either alone leaves a specific class of problem invisible, and the two…
What we do not know about retatrutide, listed explicitly Replied, post #53 · Compounds › Retatrutide · 12 Jan 2025 · 2 likes Post #52 is right about the mechanism and I think understates the practical bit. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this…
Follow-up: Individual participant data versus aggregate data Replied, post #74 · Evidence › Meta-analyses · 10 Jan 2025 · 11 likes On Individual participant data versus aggregate, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the…
When "no data" is the complete and final answer Replied, post #57 · Compounds › Other compounds · 3 Jan 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Body image changing more slowly than the body Replied, post #116 · Wellbeing › Mental health · 24 Dec 2024 · 15 likes Thank you for the correction. I would rather find out here than later.
Building a sensible monitoring schedule with your prescriber Replied, post #8 · Clinical › Bloodwork · 18 Dec 2024 · 0 likes Sensible. I would want the same detail before I acted on it either.
[2026 update] New subcategory: rationale and scope Replied, post #67 · Meta › Announcements · 15 Dec 2024 · 0 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists. I have changed my…
The report format the maintainers ask for, and why each field is there — what changed… Started this topic · Sourcing › Vendor reports · 11 Dec 2024 · 42 likes The report format the maintainers ask for, and why each field is there — what changed since Writing it up because I had to work it out twice and would rather nobody…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #119 · Clinical › Prescriber conversations · 10 Dec 2024 · 0 likes Nothing here is medical advice, and this subcategory exists to help people ask better questions rather than to answer them. The reasoning is more useful than the…
Injection-site reactions: describing them precisely enough to be useful Replied, post #49 · Practice › Side effects · 5 Dec 2024 · 15 likes Where I part company with post #47, and it is a narrow parting. Tracking severity on a simple scale with dates is far more useful than describing it afterwards. Memory…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #51 · Compounds › Semaglutide · 29 Nov 2024 · 1 like Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #92 · Clinical › Prescriber conversations · 23 Nov 2024 · 15 likes Post #89 is right about the mechanism and I think understates the practical bit. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #71 · Clinical › Prescriber conversations · 17 Nov 2024 · 27 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. The rule of thumb is fine; the edge cases are where it…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #82 · Sourcing › Independent verification · 24 Sep 2024 · 3 likes Something worth flagging about Splitting a vial: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
When to suspect the method rather than the sample Replied, post #15 · Analytics › Method validation · 22 Sep 2024 · 26 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
The C-cell question: rodent findings and their human context — what changed since Replied, post #56 · Compounds › Semaglutide · 17 Sep 2024 · 0 likes On post #55 — agreed on the reasoning, with one qualification. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #5 · Compounds › Other compounds · 16 Sep 2024 · 0 likes PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #10 · Compounds › Semaglutide · 13 Sep 2024 · 6 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
Converting between mg/mL and units per dose, both directions Replied, post #8 · Practice › Reconstitution · 1 Sep 2024 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
The topic list is dense — is that deliberate? Replied, post #17 · Meta › Site feedback · 23 Aug 2024 · 23 likes Post #13 and I disagree about the size of the effect, not about the direction. Genuine question rather than a rhetorical one: has anyone here actually observed topic…
Guidelines revision: what changed and why Replied, post #14 · Meta › Announcements · 25 Jul 2024 · 3 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #124 · Compounds › Retatrutide · 24 Jul 2024 · 3 likes What I would tell a new member reading about Retatrutide dose escalation for the first time: the confident posts are not the reliable ones, and the reliable ones are…
Promotion criteria, and the one that stops most nominations Replied, post #15 · Documentation › Doc review · 10 Jul 2024 · 33 likes Promotion criteria: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
The mass-error checker and its intended scope Replied, post #105 · Data & Tools › Calculators · 7 Jul 2024 · 15 likes The most common input error is entering the vial mass in the concentration field. It produces a plausible number, which is why it survives. That is where I would start,…
Assessing a warm arrival: the decision process — one year on Replied, post #59 · Sourcing › Logistics · 30 May 2024 · 3 likes Where I would push back on the Assessing a warm arrival consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.